RNF138P2

Across TCGA pan-cancer cohorts, RNF138P2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNF138P2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNF138P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNF138P2 expression acts as an unfavorable survival marker.

BLCA, LIHC, and LUSC are the cancer types where RNF138P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.108	0.631	<.001	144	view →
LIHC	OS	Tertile	All	0.118	0.783	<.001	54	view →
LUSC	OS	Tertile	II,III,IV	0.250	0.778	.007	54	view →
SARC	OS	Tertile	All	0.458	0.846	<.001	36	view →
LAML	DFS	Tertile	All	0.140	0.582	.020	36	view →
UCEC	OS	Tertile	All	0.727	0.876	.008	24	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
STAD	OS	Tertile	III,IV	0.171	0.510	.018	18	view →
KIRP	OS	Tertile	All	0.250	0.709	.032	15	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNF138P2–BLCA (DFS)

Open the BLCA breakdown →